STOCK TITAN

IQVIA subsidiary raises $2B through completed note sale

Net proceeds are designated for the subsidiary’s 2026 notes, partial revolving credit facility repayment and offering fees and expenses.

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

IQVIA Holdings Inc. reported that its wholly owned subsidiary, IQVIA Inc., completed the issuance and sale of notes with $2,000,000,000 in gross proceeds. The unsecured notes bear interest at 6.375% per year and mature on March 15, 2034. Net proceeds will be used to redeem in full the subsidiary’s 5.000% senior notes due 2026, repay a portion of its outstanding revolving credit facility indebtedness, and pay offering fees and expenses.

Interest is payable semi-annually on March 15 and September 15, beginning March 15, 2027. The issuer may redeem the notes before maturity, subject to a customary make-whole premium; before September 15, 2029, the notes are also subject to a customary “equity claw” redemption right. After that date, a redemption premium declines from 3.188% to 0.000%.

Positive

  • None.

Negative

  • None.

Filing Explained

The additional structural detail is that the notes are unsecured obligations of wholly owned subsidiary IQVIA Inc., with certain subsidiaries as guarantors; the filing locates the issuer obligation at IQVIA Inc., rather than describing the notes as issued directly by parent IQVIA Holdings.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Gross proceeds $2,000,000,000 Issuance and sale of the notes by IQVIA Inc.
Notes’ annual interest rate 6.375% per year Interest payable semi-annually
Notes’ maturity March 15, 2034 Senior notes issued by IQVIA Inc.
First interest payment March 15, 2027 Interest is payable semi-annually on March 15 and September 15
Existing notes designated for redemption 5.000% senior notes due 2026 Net proceeds will be used to redeem them in full
Early redemption date September 15, 2029 The notes may be redeemed before this date subject to a customary make-whole premium and equity claw right
Redemption premium 3.188% to 0.000% Premium declines after September 15, 2029
senior notes financial
"6.375% senior notes due 2034"
Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.
Indenture financial
"pursuant to an Indenture"
An indenture is a legal agreement between a company that borrows money by issuing bonds and the people who buy those bonds. It explains the rules the company must follow, like paying back the money and keeping certain financial promises. This document helps both sides understand their rights and responsibilities.
make-whole premium financial
"subject to a customary make-whole premium"
A make-whole premium is an extra payment a borrower must give bondholders when repaying debt early to compensate them for lost future interest; think of it as a lump-sum “catch-up” to leave lenders financially where they would have been if the loan had run its full term. It matters to investors because it affects how much they receive on early redemption and influences a company’s decision to refinance or repay debt, altering bond value and expected returns.
equity claw financial
"customary “equity claw” redemption right"
revolving credit facility financial
"outstanding indebtedness under the Issuer’s revolving credit facility"
A revolving credit facility is a type of loan that a business can borrow from whenever it needs money, up to a set limit. It’s like having a credit card for companies—allowing them to borrow, pay back, and borrow again as needed, providing flexibility for managing cash flow or funding short-term expenses.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did IQVIA (IQV) raise through its subsidiary’s 2034 notes?

IQVIA Inc. completed the sale of notes with $2,000,000,000 in gross proceeds. The notes bear interest at 6.375% per year and mature on March 15, 2034.

How will IQVIA use the notes’ proceeds?

The net proceeds will be used to redeem in full the subsidiary’s 5.000% senior notes due 2026, repay a portion of its outstanding revolving credit facility indebtedness, and pay fees and expenses related to the notes offering.

When can the issuer redeem IQV’s 2034 notes early?

The issuer may redeem the notes before maturity, subject to a customary make-whole premium. Before September 15, 2029, a customary “equity claw” redemption right also applies; thereafter, a redemption premium declines from 3.188% to 0.000%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001478242 0001478242 2026-09-23 2026-09-23
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 23, 2026

 

 

IQVIA HOLDINGS INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-35907   27-1341991

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

2400 Ellis Road

Durham, North Carolina

(Address of principal executive offices)

 

27703

(Zip Code)

Registrant’s telephone number, including area code: (919) 998-2000

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading

Symbol

 

Name of Each Exchange

on which Registered

Common Stock, par value $0.01 per share   IQV   New York Stock Exchange

 

 
 


Item 1.01

Entry into a Material Definitive Agreement

Notes Offering and Notes Indenture

On September 23, 2026, IQVIA Inc. (the “Issuer”), a wholly owned subsidiary of IQVIA Holdings Inc., completed the issuance and sale of $2,000,000,000 in gross proceeds of 6.375% senior notes due 2034 (the “Notes”).

The Notes were issued pursuant to an Indenture, dated September 23, 2026 (the “Indenture”), among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the Notes, and certain subsidiaries of the Issuer as guarantors.

The net proceeds from the Notes offering will be used to redeem in full the Issuer’s Senior 5.000% Notes due 2026, to repay a portion of the outstanding indebtedness under the Issuer’s revolving credit facility and to pay fees and expenses related to the Notes offering.

The Notes are unsecured obligations of the Issuer, will mature on March 15, 2034, unless earlier repurchased or redeemed in accordance with their terms, and will bear interest at the rate of 6.375% per year, with interest payable semi-annually on March 15 and September 15 of each year, beginning on March 15, 2027.

The Issuer may redeem the Notes prior to their final stated maturity, subject to a customary make-whole premium, at any time prior to September 15, 2029 (subject to a customary “equity claw” redemption right) and thereafter subject to a redemption premium declining from 3.188% to 0.000%.

The foregoing description of the Notes and the Indenture is qualified in its entirety by reference to the Indenture relating thereto, a copy of which is filed as Exhibit 4.1 to this Current Report on Form 8-K.

 

Item 2.03

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

The information set forth above under Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.

 

Item 9.01

Financial Statements and Exhibits

(d) Exhibits.

 

Exhibit
No.

 

Description

4.1   Indenture, dated September 23, 2026, among IQVIA Inc., as Issuer, U.S. Bank Trust Company, National Association, as trustee of the Notes, and certain subsidiaries of the Issuer as guarantors.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 23, 2026

 

IQVIA HOLDINGS INC.
By:  

/s/ Eric M. Sherbet

  Eric M. Sherbet
  Executive Vice President and General Counsel

Filing Exhibits & Attachments

4 documents

Keep reading